181 related articles for article (PubMed ID: 38251600)
21. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.
Brito-Zerón P; Acar-Denizli N; Ng WF; Horváth IF; Rasmussen A; Seror R; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Armagan B; Kruize AA; Kwok SK; Kvarnstrom M; Praprotnik S; Sene D; Gerli R; Solans R; Rischmueller M; Mandl T; Suzuki Y; Isenberg D; Valim V; Wiland P; Nordmark G; Fraile G; Bootsma H; Nakamura H; Giacomelli R; Devauchelle-Pensec V; Hofauer B; Bombardieri M; Trevisani VFM; Hammenfors D; Pasoto SG; Retamozo S; Gheita TA; Atzeni F; Morel J; Vollenweider C; Zeher M; Sivils K; Xu B; Bombardieri S; Sandhya P; De Vita S; Minniti A; Sánchez-Guerrero J; Kilic L; van der Heijden E; Park SH; Wahren-Herlenius M; Mariette X; Ramos-Casals M;
Rheumatology (Oxford); 2020 Sep; 59(9):2350-2359. PubMed ID: 31873754
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of the effect of Sjögren's syndrome on adverse pregnancy outcomes.
Geng B; Zhang K; Huang X; Chen Y
Clinics (Sao Paulo); 2022; 77():100140. PubMed ID: 36403428
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of fetal thymus size in maternal autoimmune diseases: systemic lupus erythematosus, Sjögren's syndrome and antiphospholipid antibody syndrome.
Uyan Hendem D; Oluklu D; Menekse Beser D; Yildirim M; Tugrul Ersak D; Tanacan A; Sahin D
Arch Gynecol Obstet; 2024 Apr; 309(4):1421-1427. PubMed ID: 37037914
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study.
Fisher BA; Szanto A; Ng WF; Bombardieri M; Posch MG; Papas AS; Farag AM; Daikeler T; Bannert B; Kyburz D; Kivitz AJ; Carsons SE; Isenberg DA; Barone F; Bowman SJ; Espié P; Floch D; Dupuy C; Ren X; Faerber PM; Wright AM; Hockey HU; Rotte M; Milojevic J; Avrameas A; Valentin MA; Rush JS; Gergely P
Lancet Rheumatol; 2020 Mar; 2(3):e142-e152. PubMed ID: 38263652
[TBL] [Abstract][Full Text] [Related]
25. Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.
Heazell AE; Hayes DJ; Whitworth M; Takwoingi Y; Bayliss SE; Davenport C
Cochrane Database Syst Rev; 2019 May; 5(5):CD012245. PubMed ID: 31087568
[TBL] [Abstract][Full Text] [Related]
26. [Isolated congenital heart block in undifferentiated connective tissue disease and in primary Sjögren's syndrome: a clinical study of 81 pregnancies in 41 patients].
Grava C; Ruffatti A; Milanesi O; Favaro M; Tonello M; Calligaro A; Del Ross T; Todesco S
Reumatismo; 2005; 57(3):180-6. PubMed ID: 16258602
[TBL] [Abstract][Full Text] [Related]
27. Increased risk of adverse gestational outcomes in pregnant women with primary Sjögren's syndrome.
Tan Z; Shao M; Zhou Y; Wang L; Ma Y; Xiang N; Yuan X; Wang B; Xie X; Zhou M; Wang Y; Li S; Li X
RMD Open; 2024 May; 10(2):. PubMed ID: 38806189
[TBL] [Abstract][Full Text] [Related]
28. The impact of primary Sjogren's syndrome on pregnancy outcome: our series and review of the literature.
De Carolis S; Salvi S; Botta A; Garofalo S; Garufi C; Ferrazzani S; De Carolis MP
Autoimmun Rev; 2014 Feb; 13(2):103-7. PubMed ID: 24044939
[TBL] [Abstract][Full Text] [Related]
29. Impact of Sjögren's syndrome on maternal and fetal outcomes following pregnancy: a systematic review and meta-analysis of studies published between years 2007-2022.
Yang Y; Huang XX; Huo RX; Lin JY
Arch Gynecol Obstet; 2024 Apr; 309(4):1135-1149. PubMed ID: 37921880
[TBL] [Abstract][Full Text] [Related]
30. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
[TBL] [Abstract][Full Text] [Related]
31. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement.
Abbara S; Seror R; Henry J; Chretien P; Gleizes A; Hacein-Bey-Abina S; Mariette X; Nocturne G
RMD Open; 2019; 5(2):e001033. PubMed ID: 31673417
[TBL] [Abstract][Full Text] [Related]
32. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.
Gurol-Urganci I; Jardine JE; Carroll F; Draycott T; Dunn G; Fremeaux A; Harris T; Hawdon J; Morris E; Muller P; Waite L; Webster K; van der Meulen J; Khalil A
Am J Obstet Gynecol; 2021 Nov; 225(5):522.e1-522.e11. PubMed ID: 34023315
[TBL] [Abstract][Full Text] [Related]
33. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
Ozek D; Kemer OE; Omma A
Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
[TBL] [Abstract][Full Text] [Related]
34. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
[TBL] [Abstract][Full Text] [Related]
35. Incidence of small-for-gestational-age infant birthweight following early intertwin fetal growth discordance in dichorionic and monochorionic twin pregnancies.
Reforma LG; Febres-Cordero D; Trochtenberg A; Modest AM; Collier AY; Spiel MH
Am J Obstet Gynecol; 2022 May; 226(5):726.e1-726.e9. PubMed ID: 34838799
[TBL] [Abstract][Full Text] [Related]
36. Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England.
Subramanian A; Lee SI; Phillips K; Toulis KA; Kempegowda P; O'Reilly MW; Adderley NJ; Thangaratinam S; Arlt W; Nirantharakumar K
BMC Med; 2022 Aug; 20(1):298. PubMed ID: 36038914
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan.
Sugawara E; Kato M; Fujieda Y; Oku K; Bohgaki T; Yasuda S; Umazume T; Morikawa M; Watari H; Atsumi T
Lupus; 2019 Oct; 28(12):1407-1416. PubMed ID: 31551035
[TBL] [Abstract][Full Text] [Related]
38. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study.
Brucato A; Doria A; Frassi M; Castellino G; Franceschini F; Faden D; Pisoni MP; Solerte L; Muscarà M; Lojacono A; Motta M; Cavazzana I; Ghirardello A; Vescovi F; Tombini V; Cimaz R; Gambari PF; Meroni PL; Canesi B; Tincani A
Lupus; 2002; 11(11):716-21. PubMed ID: 12475001
[TBL] [Abstract][Full Text] [Related]
39. Association between IVF/ICSI treatment and preterm birth and major perinatal outcomes among dichorionic-diamnionic twin pregnancies: A seven-year retrospective cohort study.
Lin D; Li P; Fan D; Chen G; Wu S; Ye S; Ma H; Rao J; Zhou Z; Zeng M; Huang Z; Guo X; Liu Z
Acta Obstet Gynecol Scand; 2021 Jan; 100(1):162-169. PubMed ID: 32865233
[TBL] [Abstract][Full Text] [Related]
40. Clinical utility of circulating anti-N-methyl-
Tay SH; Fairhurst AM; Mak A
Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
